| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Adams Helen C. is a Director at IMMX. Recent filings cover 1 purchase and 0 sales. Those positions are worth an estimated $2.0M at current prices.
Adams Helen C.'s largest disclosed position is in IMMX as Director, worth about $2.0M. Net of sales, the recent Form 4 record there shows accumulation of 13,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 12, 2023 | IMMX Immix Biopharma, Inc. | Director | Buy | 13,000 | $2.96 | $38,491.70 | New | +66.2% | -33.1% |